ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,946, issued on Oct. 6, was assigned to Animal Ethics Pty Ltd (Yarra Glen, Australia). "Topical anaesthetic composition having improved vasoc... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,947, issued on Oct. 6, was assigned to LIQMEDS WORLDWIDE Ltd. (Weedon, Great Britain). "Oral liquid formulation of apixaban" was invented by... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,948, issued on Oct. 6, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.). "Dosage forms for TYK2 inhibitors" was invented by Sherif... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,949, issued on Oct. 6, was assigned to Novartis AG (Basel, Switzerland). "Crystalline forms of a BTK inhibitor" was invented by Daniela Angs... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,950, issued on Oct. 6, was assigned to Flex Pharma LLC (New Brighton, Minn.). "Amorphous nilotinib microparticles and uses thereof" was inve... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,951, issued on Oct. 6, was assigned to GENENTECH INC. (South San Francisco, Calif.). "CDK inhibitors" was invented by Zhilong Hu (Shanghai),... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,952, issued on Oct. 6, was assigned to Zhejiang Hisun Pharmaceutical Co. Ltd. (Taizhou, China) and Shanghai Aryl Pharmtech Co. Ltd. (Shanghai... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,953, issued on Oct. 6, was assigned to Rheinische-Friedrich-Wilhelms-Universitat Bonn (Bonn, Germany) and Katholieke Universiteit Leuven KU L... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,954, issued on Oct. 6, was assigned to Principia Biopharma Inc. (Morristown, N.J.). "Methods for treating drug and vaccine induced immune th... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,955, issued on Oct. 6, was assigned to SHIONOGI & Co. LTD. (Osaka, Japan). "Formulation for oral administration, comprising triazine derivat... Read More